Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma Services
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 25 Commerce Dr, Bedford, New Hampshire (NH) 03110, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3008546445 · DUNS 028180765
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-06-10
- VAIDrug Quality Assurance2024-05-24
- VAIDrug Quality Assurance2018-12-07
- NAIDrug Quality Assurance2017-02-15
- VAIDrug Quality Assurance2015-04-24
- NAIDrug Quality Assurance2014-10-30
- VAIDrug Quality Assurance2009-09-04
Drugs this plant is listed as making
3 distinct drugs across 4 products name this site in their FDA label.
- Human SecretinChiRhoClin, Inc.
- OctreotideChiesi USA, Inc.
- sacrosidaseQOL Medical, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.